Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
NCT06569368
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Rectal Adenocarcinoma
Interventions
DRUG:
Metronidazole
Sponsor
M.D. Anderson Cancer Center